Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Selinexor in Combination With Ixazomib for the Treatment of Advanced Sarcoma
Phase 1
Withdrawn
- Conditions
- LiposarcomaMalignant Peripheral Nerve Sheath TumorsAlveolar Soft Part SarcomaEwing SarcomaSarcoma
- Interventions
- First Posted Date
- 2019-03-19
- Last Posted Date
- 2020-11-27
- Lead Sponsor
- Matthew Ingham
- Registration Number
- NCT03880123
- Locations
- 🇺🇸
Columbia University Medical Center, New York, New York, United States
News
No news found